OLUSHOLA OLORUNNIPA

Concepts (59)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Prone Position
1
2021
32
0.690
Why?
Facial Injuries
1
2021
23
0.690
Why?
Patient Positioning
1
2021
50
0.670
Why?
Pressure Ulcer
1
2021
70
0.670
Why?
Mammaplasty
2
2020
44
0.250
Why?
Dentition
1
2021
5
0.180
Why?
Mastectomy, Subcutaneous
1
2020
2
0.160
Why?
Nipples
1
2020
8
0.160
Why?
Perforator Flap
1
2020
8
0.160
Why?
Respiration, Artificial
1
2021
499
0.140
Why?
Endoscopy
1
2018
270
0.120
Why?
Craniosynostoses
1
2018
156
0.120
Why?
Breast Neoplasms
2
2020
2617
0.110
Why?
Granular Cell Tumor
1
2014
3
0.110
Why?
Thoracic Wall
1
2014
40
0.100
Why?
Mastectomy
1
2013
75
0.100
Why?
Angiography
1
2013
184
0.100
Why?
Surgical Flaps
1
2013
180
0.090
Why?
Skin
1
2013
543
0.080
Why?
Ischemia
1
2013
354
0.080
Why?
HIV-2
1
2006
8
0.060
Why?
Gene Products, tat
1
2006
27
0.060
Why?
HIV Antibodies
1
2006
69
0.060
Why?
Aged
2
2021
20897
0.050
Why?
Esthetics
1
2020
39
0.040
Why?
Humans
6
2021
130444
0.030
Why?
Blood Loss, Surgical
1
2018
168
0.030
Why?
Patient Satisfaction
1
2020
451
0.030
Why?
Male
1
2021
64506
0.030
Why?
HIV Infections
1
2006
2012
0.030
Why?
Mastectomy, Segmental
1
2014
39
0.030
Why?
Middle Aged
4
2020
28393
0.030
Why?
Sentinel Lymph Node Biopsy
1
2014
67
0.030
Why?
Coloring Agents
1
2013
70
0.030
Why?
Carcinoma, Ductal, Breast
1
2014
87
0.030
Why?
Indocyanine Green
1
2013
51
0.030
Why?
Lasers
1
2013
112
0.020
Why?
Incidental Findings
1
2014
124
0.020
Why?
Necrosis
1
2013
195
0.020
Why?
Lymph Node Excision
1
2014
160
0.020
Why?
Intraoperative Care
1
2013
121
0.020
Why?
Length of Stay
1
2018
1393
0.020
Why?
Neoplasm Invasiveness
1
2014
630
0.020
Why?
Retrospective Studies
2
2020
17633
0.020
Why?
Adult
3
2020
31122
0.020
Why?
Female
4
2020
70349
0.020
Why?
tat Gene Products, Human Immunodeficiency Virus
1
2006
32
0.020
Why?
Postoperative Complications
1
2018
3105
0.010
Why?
Enzyme-Linked Immunosorbent Assay
1
2006
783
0.010
Why?
United States
1
2020
11828
0.010
Why?
Immunoglobulin G
1
2006
790
0.010
Why?
Prospective Studies
1
2013
6445
0.010
Why?
Survival Analysis
1
2006
1501
0.010
Why?
Infant
1
2018
13281
0.010
Why?
Treatment Outcome
1
2018
12853
0.010
Why?
Longitudinal Studies
1
2006
1487
0.010
Why?
Disease Progression
1
2006
2204
0.010
Why?
Time Factors
1
2006
6188
0.010
Why?
Risk Factors
1
2006
10983
0.010
Why?
OLORUNNIPA's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (59)
Explore
_
Co-Authors (3)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_